Cite
A novel Alzheimer's disease prognostic signature: identification and analysis of glutamine metabolism genes in immunogenicity and immunotherapy efficacy.
MLA
Wu, Zixuan, et al. “A Novel Alzheimer’s Disease Prognostic Signature: Identification and Analysis of Glutamine Metabolism Genes in Immunogenicity and Immunotherapy Efficacy.” Scientific Reports, vol. 13, no. 1, Apr. 2023, pp. 1–15. EBSCOhost, https://doi.org/10.1038/s41598-023-33277-x.
APA
Wu, Z., Liu, P., Huang, B., Deng, S., Song, Z., Huang, X., Yang, J., & Cheng, S. (2023). A novel Alzheimer’s disease prognostic signature: identification and analysis of glutamine metabolism genes in immunogenicity and immunotherapy efficacy. Scientific Reports, 13(1), 1–15. https://doi.org/10.1038/s41598-023-33277-x
Chicago
Wu, Zixuan, Ping Liu, Baisheng Huang, Sisi Deng, Zhenyan Song, Xindi Huang, Jing Yang, and Shaowu Cheng. 2023. “A Novel Alzheimer’s Disease Prognostic Signature: Identification and Analysis of Glutamine Metabolism Genes in Immunogenicity and Immunotherapy Efficacy.” Scientific Reports 13 (1): 1–15. doi:10.1038/s41598-023-33277-x.